Latest filing published 27 Feb 2026 for PFIZER INC, €1.1M. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Michael McDermott is a declared insider of Pfizer Inc (chief executive), with filings sourced from SEC (Form 4). We count 9 filings; the first trade dates from 23 February 2022 and the latest from 25 February 2026.
Not one of the filings records a straightforward purchase or sale on the market. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
The latest filing, published on 27 February 2026, reports an option exercise of €1.1M in Pfizer Inc. Filings reach the SEC (Form 4) feed a median of 3 days after the trade. US insiders must file a Form 4 within two business days of a trade. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
9 of 9 declarations